EGFR inhibition in lung adenocarcinoma upregulates cell surface expression of the placental antigen ALPP and enhances efficacy of ALPP-ADC therapy https://www.biorxiv.org/content/10.1101/2023.03.27.534173v1?med=mas
EGFR inhibition in lung adenocarcinoma upregulates cell surface expression of the placental antigen ALPP and enhances efficacy of ALPP-ADC therapy https://www.biorxiv.org/content/10.1101/2023.03.27.534173v1?med=mas